Animal models of muscular dystrophy

Progress in Molecular Biology and Translational Science

Volumn 105, Issue , 2012, Pages 83-111

  Ng, Rainer ^a   Banks, Glen B ^a   Hall, John K ^a   Muir, Lindsey A ^b   Ramos, Julian N ^b   Wicki, Jacqueline ^a   Odom, Guy L ^a   Konieczny, Patryk ^a   Seto, Jane ^a   Chamberlain, Joel R ^a   Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82655173270     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394596-9.00004-4     Document Type: Chapter

References (200)

1. A.E. Emery The muscular dystrophies Lancet 359 2002 687 695 (Pubitemid 34203773)
2. D. Bansal, K. Miyake, S.S. Vogel, S. Groh, C.C. Chen, and R. Williamson Defective membrane repair in dysferlin-deficient muscular dystrophy Nature 423 2003 168 172 (Pubitemid 36569539)
3. A.L. Arnett, J.R. Chamberlain, and J.S. Chamberlain Therapy for neuromuscular disorders Curr Opin Genet Dev 19 2009 290 297
4. L.M. Kunkel Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy Nature 322 1986 73 77 (Pubitemid 16061511)
5. A.P. Monaco, R.L. Neve, C. Coletti-Feener, C.J. Bertelson, D.M. Kurnit, and L.M. Kunkel Isolation of candidate cDNA clones for portions of the Duchenne muscular dystrophy gene Nature 323 1986 646 650 (Pubitemid 16008561)
6. A.E. Emery, and F. Muntoni Duchenne muscular dystrophy 3rd ed. 2003 Oxford University Press Oxford
7. S. Abmayr, and J. Chamberlain The structure and function of dystrophin S.J. Winder, Molecular mechanisms of muscular dystrophies 2006 Landes Biosciences Georgetown 14 34
8. J.M. Ervasti Structure and function of the dystrophin-glycoprotein complex S.J. Winder, Molecular mechanisms of muscular dystrophies 2006 Landes Biosciences Georgetown 1 13
9. G.B. Banks, and J.S. Chamberlain The value of mammalian models for Duchenne muscular dystrophy in developing therapeutic strategies Curr Top Dev Biol 84 2008 431 453
10. G. Bulfield, W.G. Siller, P.A. Wight, and K.J. Moore X chromosome-linked muscular dystrophy (mdx) in the mouse Proc Natl Acad Sci USA 81 1984 1189 1192 (Pubitemid 14171480)
11. P. Sicinski, Y. Geng, A.S. Ryder-Cook, E.A. Barnard, M.G. Darlison, and P.J. Barnard The molecular basis of muscular dystrophy in the mdx mouse: a point mutation Science 244 1989 1578 1580 (Pubitemid 19189735)
12. W.B. Im, S.F. Phelps, E.H. Copen, E.G. Adams, J.L. Slightom, and J.S. Chamberlain Differential expression of dystrophin isoforms in strains of mdx mice with different mutations Hum Mol Genet 5 1996 1149 1153 (Pubitemid 26318554)
13. J.S. Chamberlain, J. Metzger, M. Reyes, D. Townsend, and J.A. Faulkner Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma FASEB J 21 2007 2195 2204 (Pubitemid 47026454)
14. K. Matsumura, J.M. Ervasti, K. Ohlendieck, S.D. Kahl, and K.P. Campbell Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle Nature 360 1992 588 591 (Pubitemid 23000708)
15. M. Takemitsu, S. Ishiura, R. Koga, K. Kamakura, K. Arahata, and I. Nonaka Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice Biochem Biophys Res Commun 180 1991 1179 1186
16. G.R. Coulton, N.A. Curtin, J.E. Morgan, and T.A. Partridge The mdx mouse skeletal muscle myopathy: II. Contractile properties Neuropathol Appl Neurobiol 14 1988 299 314
17. J. Dangain, and G. Vrbova Muscle development in mdx mutant mice Muscle Nerve 7 1984 700 704 (Pubitemid 15209285)
18. Y. Tanabe, K. Esaki, and T. Nomura Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse Acta Neuropathol 69 1986 91 95 (Pubitemid 16146255)
19. H.H. Stedman, H.L. Sweeney, J.B. Shrager, H.C. Maguire, R.A. Panettieri, and B. Petrof The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy Nature 352 1991 536 539
20. G.S. Lynch, J.A. Rafael, R.T. Hinkle, N.M. Cole, J.S. Chamberlain, and J.A. Faulkner Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice Am J Physiol 272 1997 C2063 C2068 [Cell Physiol. 41]
21. V.M. Chapman, D.R. Miller, D. Armstrong, and C.T. Caskey Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice Proc Natl Acad Sci USA 86 1989 1292 1296 (Pubitemid 19061532)
22. G.A. Cox, S.F. Phelps, V.M. Chapman, and J.S. Chamberlain New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin Nat Genet 4 1993 87 93 (Pubitemid 23165920)
23. I. Danko, V. Chapman, and J.A. Wolff The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy Pediatr Res 32 1992 128 131
24. J.A. Rafael, G.A. Cox, K. Corrado, D. Jung, K.P. Campbell, and J.S. Chamberlain Forced expression of dystrophin deletion constructs reveals structure-function correlations J Cell Biol 134 1996 93 102 (Pubitemid 26231523)
25. P. Gregorevic, J.M. Allen, E. Minami, M.J. Blankinship, M. Haraguchi, and L. Meuse rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice Nat Med 12 2006 787 789 (Pubitemid 44050067)
26. G.L. Odom, P. Gregorevic, J.M. Allen, E. Finn, and J.S. Chamberlain Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice Mol Ther 16 2008 1539 1545
27. K. Wertz, and E.M. Fuchtbauer Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene Dev Dyn 212 1998 229 241 (Pubitemid 28265142)
28. E. Araki, K. Nakamura, K. Nakao, S. Kameya, O. Kobayashi, and I. Nonaka Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy Biochem Biophys Res Commun 238 1997 492 497 (Pubitemid 27464414)
29. A. Aartsma-Rus, I. Fokkema, J. Verschuuren, I. Ginjaar, J. van Deutekom, and G.J. van Ommen Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations Hum Mutat 30 2009 293 299
30. A.T. Helderman-van den Enden, C.S. Straathof, A. Aartsma-Rus, J.T. den Dunnen, B.M. Verbist, and E. Bakker Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients Neuromuscul Disord 20 2010 251 254
31. M. Kinali, V. Arechavala-Gomeza, L. Feng, S. Cirak, D. Hunt, and C. Adkin Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study Lancet Neurol 8 2009 918 928
32. N.M. Goemans, M. Tulinius, J.T. van den Akker, B.E. Burm, P.F. Ekhart, and N. Heuvelmans Systemic administration of PRO051 in Duchenne's muscular dystrophy N Engl J Med 364 2011 1513 1522
33. J.C. van Deutekom, A.A. Janson, I.B. Ginjaar, W.S. Frankhuizen, A. Aartsma-Rus, and M. Bremmer-Bout Local dystrophin restoration with antisense oligonucleotide PRO051 N Engl J Med 357 2007 2677 2686
34. J.R. Chamberlain, and J.S. Chamberlain Muscling in: gene therapies for muscular dystrophy target RNA Nat Med 16 2010 170 171
35. Y. Aoki, A. Nakamura, T. Yokota, T. Saito, H. Okazawa, and T. Nagata In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse Mol Ther 18 2010 1995 2005
36. H. Kudoh, H. Ikeda, M. Kakitani, A. Ueda, M. Hayasaka, and K. Tomizuka A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system Biochem Biophys Res Commun 328 2005 507 516 (Pubitemid 40208339)
37. A.E. Deconinck, J.A. Rafael, J.A. Skinner, S.C. Brown, A.C. Potter, and L. Metzinger Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy Cell 90 1997 717 727 (Pubitemid 27357963)
38. R.M. Grady, H. Teng, M.C. Nichol, J.C. Cunningham, R.S. Wilkinson, and J.R. Sanes Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy Cell 90 1997 729 738 (Pubitemid 27357964)
39. J. Tinsley, N. Deconinck, R. Fisher, D. Kahn, S. Phelps, and J.M. Gillis Expression of full-length utrophin prevents muscular dystrophy in mdx mice Nat Med 4 1998 1441 1444 (Pubitemid 28553471)
40. J.A. Rafael, J.M. Tinsley, A.C. Potter, A.E. Deconinck, and K.E. Davies Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice Nat Genet 19 1998 79 82 (Pubitemid 28242029)
41. K. Chandrasekharan, J.H. Yoon, Y. Xu, S. deVries, M. Camboni, and P.M. Janssen A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy Sci Transl Med 2 2010 42ra54
42. A. Sacco, F. Mourkioti, R. Tran, J. Choi, M. Llewellyn, and P. Kraft Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice Cell 143 2010 1059 1071
43. B.J. Cooper, N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, and L.M. Kunkel The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs Nature 334 1988 154 156
44. T.A. Partridge Models of dystrophinopathy, pathological mechanisms and assessment of therapies S.C. Brown, J.A. Lacy, Dystrophin: gene, protein and cell biology 1997 Cambridge University Press Cambridge 310 331
45. S.J. Schatzberg, N.J. Olby, M. Breen, L.V. Anderson, C.F. Langford, and H.F. Dickens Molecular analysis of a spontaneous dystrophin 'knockout' dog Neuromuscul Disord 9 1999 289 295 (Pubitemid 29301708)
46. B.A. Valentine, N.J. Winand, D. Pradhan, N.S. Moise, A. de Lahunta, and J.N. Kornegay Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review Am J Med Genet 42 1992 352 356
47. Y. Shimatsu, K. Katagiri, T. Furuta, M. Nakura, Y. Tanioka, and K. Yuasa Canine X-linked muscular dystrophy in Japan (CXMDJ) Exp Anim 52 2003 93 97 (Pubitemid 41349972)
48. Z. Wang, C.S. Kuhr, J.M. Allen, M. Blankinship, P. Gregorevic, and J.S. Chamberlain Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression Mol Ther 15 2007 1160 1166 (Pubitemid 46813619)
49. E. Meryon On granular and fatty degeneration of the voluntary muscles Med Chir Trans 35 73-84 1852 1
50. G.B. Duchenne Récherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclerosique Arch Gen Med 11 1868 5 25
51. H.W. Kloepfer, and C. Talley Autosomal recessive inheritance of Duchennetype muscular dystrophy Ann Hum Genet 22 1958 138 143
52. E.P. Hoffman, R.H. Brown Jr., and L.M. Kunkel Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 51 1987 919 928
53. J.M. Ervasti, and K.P. Campbell Membrane organization of the dystrophin-glycoprotein complex Cell 66 1991 1121 1131 (Pubitemid 121001402)
54. S.L. Roberds, F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, and R.D. Anderson Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy Cell 78 1994 625 633 (Pubitemid 24268585)
55. C.G. Bonnemann, R. Modi, S. Noguchi, Y. Mizuno, M. Yoshida, and E. Gussoni Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex Nat Genet 11 1995 266 273
56. S. Noguchi, E.M. McNally, K. Ben Othmane, Y. Hagiwara, Y. Mizuno, and M. Yoshida Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy Science 270 1995 819 822
57. V. Nigro, E. de Sa Moreira, G. Piluso, M. Vainzof, A. Belsito, and L. Politano Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene Nat Genet 14 1996 195 198 (Pubitemid 26338803)
58. F. Homburger, J.R. Baker, C.W. Nixon, and G. Wilgram New hereditary disease of Syrian hamsters. Primary, generalized polymyopathy and cardiac necrosis Arch Intern Med 110 1962 660 662
59. V. Nigro, G. Piluso, A. Belsito, L. Politano, A.A. Puca, and S. Papparella Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein Hum Mol Genet 5 1996 1179 1186 (Pubitemid 26318558)
60. V. Nigro, Y. Okazaki, A. Belsito, G. Piluso, Y. Matsuda, and L. Politano Identification of the Syrian hamster cardiomyopathy gene Hum Mol Genet 6 1997 601 607 (Pubitemid 27142112)
61. S.S. Awad, and J.D. Welty Comparisons of hemodynamics throughout the life span of the Bio 14.6 cardiomyopathic with the F1B normal hamster Comp Biochem Physiol A Comp Physiol 97 1990 487 491
62. A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, and Y. Murakami Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex Proc Natl Acad Sci USA 94 1997 13873 13878 (Pubitemid 28009677)
63. A. Sakamoto Molecular pathogenesis of severe cardiomyopathy in the TO-2 hamster Exp Clin Cardiol 8 2003 143 146 (Pubitemid 38324797)
64. A.A. Hack, M.E. Groh, and E.M. McNally Sarcoglycans in muscular dystrophy Microsc Res Tech 48 2000 167 180 (Pubitemid 30086190)
65. R. Coral-Vazquez, R.D. Cohn, S.A. Moore, J.A. Hill, R.M. Weiss, and R.L. Davisson Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy Cell 98 1999 465 474 (Pubitemid 29402484)
66. J.A. Burbach, E.H. Schlenker, and J.L. Johnson Morphometry, histochemistry, and contractility of dystrophic hamster diaphragm Am J Physiol 253 1987 R275 84
67. J.P. Wansapura, D.P. Millay, R.S. Dunn, J.D. Molkentin, and D.W. Benson Magnetic resonance imaging assessment of cardiac dysfunction in delta-sarcoglycan null mice Neuromuscul Disord 21 2011 68 73
68. A.A. Hack, C.T. Ly, F. Jiang, C.J. Clendenin, K.S. Sigrist, and R.L. Wollmann Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin J Cell Biol 142 1998 1279 1287 (Pubitemid 28429109)
69. M. Ben Hamida, C. Ben Hamida, M. Zouari, S. Belal, and F. Hentati Limb-girdle muscular dystrophy 2C: clinical aspects Neuromuscul Disord 6 1996 493 494 (Pubitemid 27052795)
70. M. Durbeej, R.D. Cohn, R.F. Hrstka, S.A. Moore, V. Allamand, and B.L. Davidson Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E Mol Cell 5 2000 141 151 (Pubitemid 30105443)
71. K. Araishi, T. Sasaoka, M. Imamura, S. Noguchi, H. Hama, and E. Wakabayashi Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice Hum Mol Genet 8 1999 1589 1598 (Pubitemid 29423867)
72. R.D. Cohn, M. Durbeej, S.A. Moore, R. Coral-Vazquez, S. Prouty, and K.P. Campbell Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex J Clin Invest 107 2001 R1 R7
73. M. Durbeej, and K.P. Campbell Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models Curr Opin Genet Dev 12 2002 349 361 (Pubitemid 34669835)
74. Y.M. Chan, C.G. Bonnemann, H.G. Lidov, and L.M. Kunkel Molecular organization of sarcoglycan complex in mouse myotubes in culture J Cell Biol 143 1998 2033 2044 (Pubitemid 29022622)
75. D.J. Duggan, D. Manchester, K.P. Stears, D.J. Mathews, C. Hart, and E.P. Hoffman Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2) Neurogenetics 1 1997 49 58 (Pubitemid 127709609)
76. L. Klinge, G. Dekomien, A. Aboumousa, R. Charlton, J.T. Epplen, and R. Barresi Sarcoglycanopathies: can muscle immunoanalysis predict the genotype? Neuromuscul Disord 18 2008 934 941
77. M. Vainzof, M.R. Passos-Bueno, M. Canovas, E.S. Moreira, R.C. Pavanello, and S.K. Marie The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies Hum Mol Genet 5 1996 1963 1969 (Pubitemid 26413641)
78. F. Duclos, V. Straub, S.A. Moore, D.P. Venzke, R.F. Hrstka, and R.H. Crosbie Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice J Cell Biol 142 1998 1461 1471 (Pubitemid 28452596)
79. N.D. Patel, S.R. Jannapureddy, W. Hwang, I. Chaudhry, and A.M. Boriek Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan- deficient mice Am J Physiol Cell Physiol 284 2003 C962 C968
80. K. Deitz, J.A. Morrison, K. Kline, L.T. Guo, and G.D. Shelton Sarcoglycan-deficient muscular dystrophy in a Boston Terrier J Vet Intern Med 22 2008 476 480 (Pubitemid 351570519)
81. S. Schatzberg Proceedings of the American College of Veterinary Internal Medicine, 22nd annual forum, Dallas, TX 2003
82. M.W. Berchtold, H. Brinkmeier, and M. Muntener Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease Physiol Rev 80 2000 1215 1265 (Pubitemid 30452014)
83. P.R. Turner, P.Y. Fong, W.F. Denetclaw, and R.A. Steinhardt Increased calcium influx in dystrophic muscle J Cell Biol 115 1991 1701 1712 (Pubitemid 21910010)
84. C. Vandebrouck, D. Martin, S.M. Colson-Van, H. Debaix, and P. Gailly Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers J Cell Biol 158 2002 1089 1096
85. K. Culligan, N. Banville, P. Dowling, and K. Ohlendieck Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle J Appl Physiol 92 2002 435 445 (Pubitemid 34671005)
86. P. Dowling, P. Doran, and K. Ohlendieck Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy Biochem J 379 2004 479 488 (Pubitemid 38570121)
87. A. Divet, and C. Huchet-Cadiou Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice Pflugers Arch 444 2002 634 643 (Pubitemid 35461783)
88. A. Divet, A.M. Lompre, and C. Huchet-Cadiou Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice Acta Physiol Scand 184 2005 173 186 (Pubitemid 40896687)
89. J.M. Alderton, and R.A. Steinhardt Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes J Biol Chem 275 2000 9452 9460 (Pubitemid 30185173)
90. N. Mallouk, V. Jacquemond, and B. Allard Elevated subsarcolemmal Ca2 + in mdx mouse skeletal muscle fibers detected with Ca2+-activated K + channels Proc Natl Acad Sci USA 97 2000 4950 4955 (Pubitemid 30238663)
91. P.R. Turner, T. Westwood, C.M. Regen, and R.A. Steinhardt Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice Nature 335 1988 735 738
92. H. Gissel The role of Ca2 + in muscle cell damage Ann N Y Acad Sci 1066 2005 166 180
93. Y. Iwata, Y. Katanosaka, Y. Arai, M. Shigekawa, and S. Wakabayashi Dominant-negative inhibition of Ca2 + influx via TRPV2 ameliorates muscular dystrophy in animal models Hum Mol Genet 18 2009 824 834
94. D.P. Millay, S.A. Goonasekera, M.A. Sargent, M. Maillet, B.J. Aronow, and J.D. Molkentin Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism Proc Natl Acad Sci USA 106 2009 19023 19028
95. L. Klinge, S. Laval, S. Keers, F. Haldane, V. Straub, and R. Barresi From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis FASEB J 21 2007 1768 1776 (Pubitemid 46855623)
96. N.J. Lennon, A. Kho, B.J. Bacskai, S.L. Perlmutter, B.T. Hyman, and R.H. Brown Jr. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing J Biol Chem 278 2003 50466 50473 (Pubitemid 37548892)
97. R. Bashir, S. Britton, T. Strachan, S. Keers, E. Vafiadaki, and M. Lako A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B Nat Genet 20 1998 37 42 (Pubitemid 28410340)
98. J. Liu, M. Aoki, I. Illa, C. Wu, M. Fardeau, and C. Angelini Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy Nat Genet 20 1998 31 36 (Pubitemid 28410339)
99. M. Ho, C.M. Post, L.R. Donahue, H.G. Lidov, R.T. Bronson, and H. Goolsby Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency Hum Mol Genet 13 2004 1999 2010 (Pubitemid 39377824)
100. L. Klinge, J. Harris, C. Sewry, R. Charlton, L. Anderson, and S. Laval Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle Muscle Nerve 41 2010 166 173
101. J.S. Beckmann, and M. Spencer Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance Neuromuscul Disord 18 2008 913 921
102. S. Duguez, M. Bartoli, and I. Richard Calpain 3: a key regulator of the sarcomere? FEBS J 273 2006 3427 3436 (Pubitemid 44086943)
103. H. Sorimachi, S. Hata, and Y. Ono Calpain chronicle - an enzyme family under multidisciplinary characterization Proc Jpn Acad Ser B Phys Biol Sci 87 2011 287 327
104. I. Kramerova, E. Kudryashova, G. Venkatraman, and M.J. Spencer Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway Hum Mol Genet 14 2005 2125 2134 (Pubitemid 41418012)
105. I. Kramerova, E. Kudryashova, B. Wu, C. Ottenheijm, H. Granzier, and M.J. Spencer Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle Hum Mol Genet 17 2008 3271 3280
106. Y. Huang, A. de Morree, A. van Remoortere, K. Bushby, R.R. Frants, and J.T. Dunnen Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle Hum Mol Genet 17 2008 1855 1866 (Pubitemid 351791513)
107. W.A. Linke, and M. Kruger The giant protein titin as an integrator of myocyte signaling pathways Physiology 25 2010 186 198
108. M. Kruger, and W.A. Linke The giant protein titin: a regulatory node that integrates myocyte signaling pathways J Biol Chem 286 2011 9905 9912
109. M. Gautel The sarcomeric cytoskeleton: who picks up the strain? Curr Opin Cell Biol 23 2011 39 46
110. H. Haravuori, A. Vihola, V. Straub, M. Auranen, I. Richard, and S. Marchand Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene Neurology 56 2001 869 877 (Pubitemid 32290803)
111. I. Richard, C. Roudaut, S. Marchand, S. Baghdiguian, M. Herasse, and D. Stockholm Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice J Cell Biol 151 2000 1583 1590 (Pubitemid 32047605)
112. I. Kramerova, E. Kudryashova, J.G. Tidball, and M.J. Spencer Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro Hum Mol Genet 13 2004 1373 1388 (Pubitemid 38961644)
113. M. Fanin, A.C. Nascimbeni, L. Fulizio, C.P. Trevisan, M. Meznaric-Petrusa, and C. Angelini Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression Am J Pathol 163 2003 1929 1936 (Pubitemid 37310023)
114. M. Vainzof, F. de Paula, A.M. Tsanaclis, and M. Zatz The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A J Clin Pathol 56 2003 624 626 (Pubitemid 36980630)
115. K. Tagawa, C. Taya, Y. Hayashi, M. Nakagawa, Y. Ono, and R. Fukuda Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A Hum Mol Genet 9 2000 1393 1402 (Pubitemid 30312488)
116. K. Ojima, Y. Kawabata, H. Nakao, K. Nakao, N. Doi, and F. Kitamura Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy J Clin Invest 120 2010 2672 2683
117. K. Ojima, Y. Ono, C. Ottenheijm, S. Hata, H. Suzuki, and H. Granzier Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles J Mol Biol 407 2011 439 449
118. N. Ermolova, E. Kudryashova, M. Difranco, J. Vergara, I. Kramerova, and M.J. Spencer Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3 Hum Mol Genet 20 2011 3331 3345
119. K. Charton, N. Daniele, A. Vihola, C. Roudaut, E. Gicquel, and F. Monjaret Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies Hum Mol Genet 19 2010 4608 4624
120. K.A. Huebsch, E. Kudryashova, C.M. Wooley, R.B. Sher, K.L. Seburn, and M.J. Spencer Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain Hum Mol Genet 14 2005 2801 2811 (Pubitemid 41418786)
121. S.M. Garvey, C. Rajan, A.P. Lerner, W.N. Frankel, and G.A. Cox The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin Genomics 79 2002 146 149 (Pubitemid 34124016)
122. J.E. Hance, S.Y. Fu, S.C. Watkins, A.H. Beggs, and M. Michalak Alpha-actinin-2 is a new component of the dystrophin-glycoprotein complex Arch Biochem Biophys 365 1999 216 222 (Pubitemid 29391629)
123. C.A. Otey, and O. Carpen Alpha-actinin revisited: a fresh look at an old player Cell Motil Cytoskeleton 58 2004 104 111 (Pubitemid 38697587)
124. C. Chiu, R.D. Bagnall, J. Ingles, L. Yeates, M. Kennerson, and J.A. Donald Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis J Am Coll Cardiol 55 2010 1127 1135
125. K.N. North, N. Yang, D. Wattanasirichaigoon, M. Mills, S. Easteal, and A.H. Beggs A common nonsense mutation results in alpha-actinin-3 deficiency in the general population Nat Genet 21 1999 353 354 (Pubitemid 29159565)
126. N. Yang, D.G. MacArthur, J.P. Gulbin, A.G. Hahn, A.H. Beggs, and S. Easteal ACTN3 genotype is associated with human elite athletic performance Am J Hum Genet 73 2003 627 631 (Pubitemid 37076274)
127. A.K. Niemi, and K. Majamaa Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes Eur J Hum Genet 13 2005 965 969 (Pubitemid 41131745)
128. I.D. Papadimitriou, C. Papadopoulos, A. Kouvatsi, and C. Triantaphyllidis The ACTN3 gene in elite Greek track and field athletes Int J Sports Med 29 2008 352 355 (Pubitemid 351542898)
129. S.M. Roth, S. Walsh, D. Liu, E.J. Metter, L. Ferrucci, and B.F. Hurley The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes Eur J Hum Genet 16 2008 391 394 (Pubitemid 351292240)
130. P.M. Clarkson, J.M. Devaney, H. Gordish-Dressman, P.D. Thompson, M.J. Hubal, and M. Urso ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women J Appl Physiol 99 2005 154 163 (Pubitemid 40934477)
131. C.N. Moran, N. Yang, M.E. Bailey, A. Tsiokanos, A. Jamurtas, and D.G. MacArthur Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks Eur J Hum Genet 15 2007 88 93 (Pubitemid 44921671)
132. D.G. MacArthur, J.T. Seto, S. Chan, K.G. Quinlan, J.M. Raftery, and N. Turner An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance Hum Mol Genet 17 2008 1076 1086 (Pubitemid 351494181)
133. J.T. Seto, M. Lek, K.G. Quinlan, P.J. Houweling, X.F. Zheng, and F. Garton Deficiency of {alpha}-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling Hum Mol Genet 20 2011 2914 2927
134. D. Beltran-Valero de Bernabe, T. Voit, C. Longman, A. Steinbrecher, V. Straub, and Y. Yuva Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome J Med Genet 41 2004 e61
135. M. Brockington, D.J. Blake, P. Prandini, S.C. Brown, S. Torelli, and M.A. Benson Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan Am J Hum Genet 69 2001 1198 1209 (Pubitemid 33124201)
136. S.C. Brown, S. Torelli, M. Brockington, Y. Yuva, C. Jimenez, and L. Feng Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies Am J Pathol 164 2004 727 737 (Pubitemid 38364686)
137. F. Muntoni, S. Torelli, and M. Brockington Muscular dystrophies due to glycosylation defects Neurotherapeutics 5 2008 627 632
138. G. Kawahara, J.R. Guyon, Y. Nakamura, and L.M. Kunkel Zebrafish models for human FKRP muscular dystrophies Hum Mol Genet 19 2010 623 633
139. C.H. Wang, Y.M. Chan, R.H. Tang, B. Xiao, P. Lu, and E. Keramaris-Vrantsis Post-natal knockdown of fukutin-related protein expression in muscle by long-term RNA interference induces dystrophic pathology [corrected] Am J Pathol 178 2011 261 272
140. M.R. Ackroyd, L. Skordis, M. Kaluarachchi, J. Godwin, S. Prior, and M. Fidanboylu Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies Brain 132 2009 439 451
141. Y.M. Chan, E. Keramaris-Vrantsis, H.G. Lidov, J.H. Norton, N. Zinchenko, and H.E. Gruber Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies Hum Mol Genet 19 2010 3995 4006
142. S. Bortolanza, A. Nonis, F. Sanvito, S. Maciotta, G. Sitia, and J. Wei AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy Mol Ther 2011 Aug 9. doi: 10.1038/mt.2011.153. [Epub ahead of print]
143. K. van Spaendonck-Zwarts, L. van Hessem, J.D. Jongbloed, H.E. de Walle, Y. Capetanaki, and A.J. van der Kooi Desmin-related myopathy: a review and meta-analysis Clin Genet 80 2011 354 366
144. L.G. Goldfarb, and M.C. Dalakas Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease J Clin Invest 119 2009 1806 1813
145. M.C. Dalakas, K.Y. Park, C. Semino-Mora, H.S. Lee, K. Sivakumar, and L.G. Goldfarb Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene N Engl J Med 342 2000 770 780 (Pubitemid 30151921)
146. D.J. Milner, G. Weitzer, D. Tran, A. Bradley, and Y. Capetanaki Disruption of muscle architecture and myocardial degeneration in mice lacking desmin J Cell Biol 134 1996 1255 1270 (Pubitemid 26300170)
147. Z. Li, E. Colucci-Guyon, M. Pincon-Raymond, M. Mericskay, S. Pournin, and D. Paulin Cardiovascular lesions and skeletal myopathy in mice lacking desmin Dev Biol 175 1996 362 366 (Pubitemid 26160764)
148. L. Thornell, L. Carlsson, Z. Li, M. Mericskay, and D. Paulin Null mutation in the desmin gene gives rise to a cardiomyopathy J Mol Cell Cardiol 29 1997 2107 2124 (Pubitemid 27348522)
149. D.J. Milner, G.E. Taffet, X. Wang, T. Pham, T. Tamura, and C. Hartley The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function J Mol Cell Cardiol 31 1999 2063 2076 (Pubitemid 29537605)
150. D.J. Milner, M. Mavroidis, N. Weisleder, and Y. Capetanaki Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function J Cell Biol 150 2000 1283 1298
151. N. Weisleder, E. Soumaka, S. Abbasi, H. Taegtmeyer, and Y. Capetanaki Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement J Mol Cell Cardiol 36 2004 121 128 (Pubitemid 38084797)
152. A. Maloyan, and J. Robbins Autophagy in desmin-related cardiomyopathy: thoughts at the halfway point Autophagy 6 2010 665 666
153. J.W. Schrickel, F. Stockigt, W. Krzyzak, D. Paulin, Z. Li, and I. Lubkemeier Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice J Interv Card Electrophysiol 28 2010 71 80
154. X. Wang, H. Osinska, G.W. Dorn 2nd, M. Nieman, J.N. Lorenz, and A.M.
155. A. Kostareva, A. Gudkova, G. Sjoberg, I. Kiselev, O. Moiseeva, and E. Karelkina Desmin mutations in a St. Petersburg cohort of cardiomyopathies Acta Myol 25 2006 109 115 (Pubitemid 46579318)
156. H. Xu, X.-R. Wu, U.M. Wewer, and E. Engvall Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene Nat Genet 8 1994 297 302 (Pubitemid 24338744)
157. A. Helbling-Leclerc, X. Zhang, H. Topaloglu, C. Cruaud, F. Tesson, and J. Weissenbach Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy Nat Genet 11 1995 216 218
158. L.T. Guo, X.U. Zhang, W. Kuang, H. Xu, L.A. Liu, and J.T. Vilquin Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice Neuromuscul Disord 13 2003 207 215 (Pubitemid 36279425)
159. F. Geranmayeh, E. Clement, L.H. Feng, C. Sewry, J. Pagan, and R. Mein Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations Neuromuscul Disord 20 2010 241 250
160. K.I. Gawlik, and M. Durbeej Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies Skelet Muscle 1 2011 9
161. H. Xu, P. Christmas, X.R. Wu, U.M. Wewer, and E. Engvall Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse Proc Natl Acad Sci USA 91 1994 5572 5576 (Pubitemid 24174370)
162. 2J mice Hum Mol Genet 4 1995 1055 1061
163. W. Kuang, H. Xu, P.H. Vachon, L. Liu, F. Loechel, and U.M. Wewer Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models J Clin Invest 102 1998 844 852 (Pubitemid 28399618)
164. Y. Miyagoe, K. Hanaoka, I. Nonaka, M. Hayasaka, Y. Nabeshima, and K. Arahata Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy FEBS Lett 415 1997 33 39 (Pubitemid 27402044)
165. G.D. Shelton, L.A. Liu, L.T. Guo, G.K. Smith, J.S. Christiansen, and W.B. Thomas Muscular dystrophy in female dogs J Vet Intern Med 15 2001 240 244 (Pubitemid 33722467)
166. P. Bonaldo, V. Russo, F. Bucciotti, R. Doliana, and A. Colombatti Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues Biochemistry 29 1990 1245 1254 (Pubitemid 20053848)
167. H.-J. Kuo, C.L. Maslen, D.R. Keene, and R.W. Glanville Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen J Biol Chem 272 1997 26522 26529 (Pubitemid 27458872)
168. J. Schessl, Y. Zou, and C.G. Bönnemann Congenital muscular dystrophies and the extracellular matrix Semin Pediatr Neurol 13 2006 80 89 (Pubitemid 44486822)
169. P. Bernardi, and P. Bonaldo Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies Ann N Y Acad Sci 1147 2008 303 311
170. U. Specks, U. Mayer, R. Nischt, T. Spissinger, K. Mann, and R. Timpl Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan EMBO J 11 1992 4281 4290
171. J. Bethlem, and G.K. van Wijngaarden Benign myopathy, with autosomal dominant inheritance: a report on three pedigrees Brain 99 1976 91 100
172. G.J. Jöbsis, J.M. Boers, P.G. Barth, and M. de Visser Genetic localization of Bethlem myopathy Neurology 46 1996 779 782 (Pubitemid 26099648)
173. G.J. Jöbsis, H. Keizers, J.P. Vreijling, M. de Visser, M.C. Speer, and R.A. Wolterman Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures Nat Genet 14 1996 113 115 (Pubitemid 26301559)
174. M.C. Speer, R. Tandan, P.N. Rao, T. Fries, J.M. Stajich, and P.A. Bolhuis Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37 Hum Mol Genet 5 1996 1043 1046 (Pubitemid 26232289)
175. O. Camacho Vanegas, E. Bertini, R.-Z. Zhang, S. Petrini, C. Minosse, and P. Sabatelli Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI Proc Natl Acad Sci USA 98 2001 7516 7521 (Pubitemid 32567980)
176. E. Demir, P. Sabatelli, V. Allamand, A. Ferreiro, B. Moghadaszadeh, and M. Makrelouf Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy Am J Hum Genet 70 2002 1446 1458 (Pubitemid 34533892)
177. P. Bonaldo, P. Braghetta, M. Zanetti, S. Piccolo, D. Volpin, and G.M. Bressan Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy Hum Mol Genet 7 1998 2135 2140 (Pubitemid 28546424)
178. W.A. Irwin, N. Bergamin, P. Sabatelli, C. Reggiani, A. Megighian, and L. Merlini Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency Nat Genet 35 2003 367 371 (Pubitemid 37486921)
179. E. Bertini, and P. Guglielmina Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy Eur J Paediatr Neurol 6 2002 193 198
180. T. Tiepolo, A. Angelin, E. Palma, P. Sabatelli, L. Merlini, and L. Nicolosi The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice Br J Pharmacol 157 2009 1045 1052
181. W.R. Telfer, A.S. Busta, C.G. Bönnemann, E.L. Feldman, and J.J. Dowling Zebrafish models of collagen VI-related myopathies Hum Mol Genet 19 2010 2433 2444
182. J.C. de Greef, R.J. Lemmers, B.G. van Engelen, S. Sacconi, S.L. Venance, and R.R. Frants Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD Hum Mutat 30 2009 1449 1459
183. V. Kowaljow, A. Marcowycz, E. Ansseau, C.B. Conde, S. Sauvage, and C. Matteotti The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein Neuromuscul Disord 17 2007 611 623 (Pubitemid 47030917)
184. R.J. Lemmers, P.J. van der Vliet, R. Klooster, S. Sacconi, P. Camano, and J.G. Dauwerse A unifying genetic model for facioscapulohumeral muscular dystrophy Science 329 2010 1650 1653
185. S.M. van der Maarel, R. Tawil, and S.J. Tapscott Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence Trends Mol Med 17 2011 252 258
186. D. Gabellini, G. D'Antona, M. Moggio, A. Prelle, C. Zecca, and R. Adami Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1 Nature 439 2006 973 977 (Pubitemid 43292415)
187. L.M. Wallace, S.E. Garwick-Coppens, R. Tupler, and S.Q. Harper RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1) Mol Ther 2011 (in press)
188. P.S. Harper, and K. Johnson Myotonic dystrophy C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited disease Vol. III 2001 McGraw-Hill New York 5525 5550
189. J.W. Miller, C.R. Urbinati, P. Teng-Umnuay, M.G. Stenberg, B.J. Byrne, and C.A. Thornton Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy EMBO J 19 2000 4439 4448
190. K.L. Taneja, M. McCurrach, M. Schalling, D. Housman, and R.H. Singer Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues J Cell Biol 128 1995 995 1002
191. L.T. Timchenko, J.W. Miller, N.A. Timchenko, D.R. DeVore, K.V. Datar, and L. Lin Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy Nucleic Acids Res 24 1996 4407 4414 (Pubitemid 26388627)
192. M. Fardaei, M.T. Rogers, H.M. Thorpe, K. Larkin, M.G. Hamshere, and P.S. Harper Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells Hum Mol Genet 11 2002 805 814 (Pubitemid 34428648)
193. M. Gomes-Pereira, T.A. Cooper, and G. Gourdon Myotonic dystrophy mouse models: towards rational therapy development Trends Mol Med 17 2011 506 517
194. A. Mankodi, E. Logigian, L. Callahan, C. McClain, R. White, and D. Henderson Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat Science 289 2000 1769 1773
195. T.M. Wheeler, K. Sobczak, J.D. Lueck, R.J. Osborne, X. Lin, and R.T. Dirksen Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA Science 325 2009 336 339
196. H. Seznec, O. Agbulut, N. Sergeant, C. Savouret, A. Ghestem, and N. Tabti Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities Hum Mol Genet 10 2001 2717 2726 (Pubitemid 33133413)
197. J.P. Orengo, P. Chambon, D. Metzger, D.R. Mosier, G.J. Snipes, and T.A. Cooper Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy Proc Natl Acad Sci USA 105 2008 2646 2651 (Pubitemid 351520567)
198. R.N. Kanadia, K.A. Johnstone, A. Mankodi, C. Lungu, C.A. Thornton, and D. Esson A muscleblind knockout model for myotonic dystrophy Science 302 2003 1978 1980 (Pubitemid 37523508)
199. A.J. Ward, M. Rimer, J.M. Killian, J.J. Dowling, and T.A. Cooper CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1 Hum Mol Genet 19 2010 3614 3622
200. L.A. Muir, and J.S. Chamberlain Emerging strategies for cell and gene therapy of the muscular dystrophies Expert Rev Mol Med 11 2009 e18